Updated Jul 16, 2026
Sanders Corazon (Corsee) D. has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.01M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 2.0K | $25.05 | $50K |
| 2026-05-27 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 212 | $309.59 | $66K |
| 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 7.8K | $0.00 | |
| 2025-09-05 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 2.7K | $337.00 | $898K |
| 2025-09-05 | ONC | BeOne Medicines Ltd. | M — Option exercise | 2.7K | $155.68 | $415K |
Sanders Corazon (Corsee) D. is a corporate insider — currently tracked as Insider of Ultragenyx Pharmaceutical Inc. (RARE). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.01M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sanders Corazon (Corsee) D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.